Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of the PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis

NCT06296953 is registered in ClinicalTrials.gov with STB INN AB as lead sponsor.

NCT NCT06296953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06296953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of the PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis
Lead sponsor
STB INN AB
Phase
Not applicable
Overall status
Completed
Start date
March 15, 2024
Completion date
August 1, 2024
Enrollment
40 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, appendicitis, appendicitis acute, peritonitis